Total Payments
$2,071
2024 Payments
$63.94
Companies
22
Transactions
116
Medicare Patients
1,439
Medicare Billing
$94,570
Payment Breakdown by Category
Food & Beverage$2,071 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,071 | 116 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $568.92 | 56 | $0 (2023) |
| PFIZER INC. | $271.80 | 13 | $0 (2022) |
| GlaxoSmithKline, LLC. | $169.70 | 4 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $165.90 | 10 | $0 (2023) |
| Relievant Medsystems, Inc. | $135.88 | 1 | $0 (2022) |
| Cardiovascular Systems Inc. | $129.16 | 1 | $0 (2021) |
| Nevro Corp. | $112.29 | 1 | $0 (2021) |
| Lilly USA, LLC | $94.46 | 5 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $80.14 | 5 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $76.20 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $63.94 | 3 | Abbott Laboratories ($24.13) |
| 2023 | $253.50 | 10 | GlaxoSmithKline, LLC. ($105.78) |
| 2022 | $522.62 | 48 | Novo Nordisk Inc ($169.94) |
| 2021 | $813.51 | 34 | Novo Nordisk Inc ($328.01) |
| 2020 | $361.76 | 18 | PFIZER INC. ($173.35) |
| 2018 | $55.83 | 3 | Ortho Dermatologics, a division of Bausch Health US, LLC ($20.60) |
All Payment Transactions
116 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: Diabetes Care | ||||||
| 08/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: RESPIRATORY | ||||||
| 06/06/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Respiratory | ||||||
| 09/27/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Diabetes | ||||||
| 09/07/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Cardio-renal | ||||||
| 08/23/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $105.78 | General |
| Category: RESPIRATORY | ||||||
| 08/10/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Cardio-renal | ||||||
| 07/13/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Cardio-renal | ||||||
| 03/16/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Cardio-renal | ||||||
| 02/23/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Cardio-renal | ||||||
| 02/21/2023 | Novo Nordisk Inc | Saxenda (Drug), Wegovy | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Obesity | ||||||
| 01/28/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Diabetes | ||||||
| 12/15/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $11.69 | General |
| 12/01/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Diabetes | ||||||
| 11/30/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $0.47 | General |
| Category: Diabetes | ||||||
| 11/17/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Diabetes | ||||||
| 11/03/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Cardio-renal | ||||||
| 10/27/2022 | Relievant Medsystems, Inc. | Intracept (Device), Intracept | Food and Beverage | Cash or cash equivalent | $135.88 | General |
| Category: Pain | ||||||
| 10/13/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $12.22 | General |
| 09/22/2022 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Neuroscience | ||||||
| 09/17/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.76 | General |
| Category: Diabetes | ||||||
| 09/16/2022 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/16/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $1.20 | General |
| Category: Diabetes | ||||||
| 09/14/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 229 | 307 | $77,804 | $23,546 |
| 2022 | 16 | 849 | 1,164 | $181,337 | $44,463 |
| 2021 | 12 | 315 | 379 | $64,929 | $22,896 |
| 2020 | 2 | 46 | 53 | $8,295 | $3,666 |
Total Patients
1,439
Total Services
1,903
Medicare Billing
$94,570
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 100 | 178 | $55,351 | $14,604 | 26.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 44 | 44 | $13,169 | $5,622 | 42.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 14 | 14 | $5,356 | $2,225 | 41.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 39 | 39 | $1,698 | $722.28 | 42.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 15 | 15 | $1,125 | $196.80 | 17.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 17 | 17 | $1,105 | $175.95 | 15.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 127 | 268 | $90,852 | $23,316 | 25.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 55 | 55 | $19,305 | $7,374 | 38.2% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 68 | 71 | $17,750 | $5,263 | 29.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 76 | 107 | $8,025 | $1,417 | 17.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 90 | 130 | $8,450 | $1,357 | 16.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 55 | 63 | $5,985 | $1,049 | 17.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 53 | 53 | $3,021 | $995.22 | 32.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $6,864 | $852.83 | 12.4% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 40 | 61 | $3,355 | $586.51 | 17.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 64 | 74 | $4,440 | $568.82 | 12.8% |
| 84154 | Psa (prostate specific antigen) measurement, free | Office | 2022 | 25 | 28 | $2,940 | $510.36 | 17.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 85 | 129 | $5,031 | $383.16 | 7.6% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2022 | 17 | 20 | $2,100 | $364.15 | 17.3% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2022 | 20 | 24 | $1,200 | $215.04 | 17.9% |
| 81003 | Automated urinalysis test | Office | 2022 | 50 | 57 | $1,425 | $126.68 | 8.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 11 | 11 | $594.00 | $84.17 | 14.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 83 | 133 | $33,567 | $13,481 | 40.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 26 | 26 | $6,915 | $3,578 | 51.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 17 | 17 | $8,364 | $2,114 | 25.3% |
About Dr. Yasmany Dominguez, DO
Dr. Yasmany Dominguez, DO is a Family Medicine healthcare provider based in Juno Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/28/2017. The National Provider Identifier (NPI) number assigned to this provider is 1710493739.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Yasmany Dominguez, DO has received a total of $2,071 in payments from pharmaceutical and medical device companies, with $63.94 received in 2024. These payments were reported across 116 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,071).
As a Medicare-enrolled provider, Dominguez has provided services to 1,439 Medicare beneficiaries, totaling 1,903 services with total Medicare billing of $94,570. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Adult Medicine, Student in an Organized Health Care Education/Training Program
- Location Juno Beach, FL
- Active Since 12/28/2017
- Last Updated 03/24/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1710493739
Products in Payments
- Ozempic (Drug) $311.29
- Kerendia (Drug) $165.90
- Rybelsus (Drug) $141.59
- Intracept (Device) $135.88
- CHANTIX (Drug) $117.45
- Omnia (Device) $112.29
- AREXVY (Drug) $105.78
- RYBELSUS (Drug) $75.47
- CONTRAVE (Drug) $64.83
- JARDIANCE (Drug) $49.45
- TRULICITY (Drug) $47.18
- PREMARIN (Drug) $46.01
- TRELEGY ELLIPTA (Drug) $44.09
- Saxenda (Drug) $40.57
- PREVNAR 13 (Biological) $37.17
- ELIQUIS (Drug) $33.71
- EMGALITY (Drug) $28.70
- TRINTELLIX (Drug) $26.94
- STIOLTO RESPIMAT (Drug) $26.75
- FREESTYLE LIBRE 3 (Device) $24.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Juno Beach
Dr. Gregory Bahtiarian, Do, DO
Family Medicine — Payments: $1,036
Family Medicine $1,036
Dr. Ronald Gazze, M.d, M.D
Family Medicine — Payments: $473.64
Family Medicine $473.64
Dr. Holly Hadley, M.d, M.D
Family Medicine — Payments: $466.15
Family Medicine $466.15
Dr. Alan Rozen, M.d, M.D
Family Medicine — Payments: $223.61
Family Medicine $223.61
Carla Dipiero, D.o, D.O
Family Medicine — Payments: $68.62
Family Medicine $68.62
Dr. Danine Fruge, M.d, M.D
Family Medicine
Family Medicine